NY Times: Prescriptions blog: F.D.A. Clears Way for Embryonic Stem Cell Trial Using Patients, by Andrew Pollack:
The world’s first authorized test in people of a treatment derivedfrom human embryonic stem cells has been cleared to begin by the Foodand Drug Administration.
The trial will test cells developed by Geron Corporation and theUniversity of California, Irvine in patients with new spinal cordinjuries. . . .